About

World BioBank™

A Service of ACORN Research - A Benefit for CRO Clients

• Biomarker consultation, collection, and oversight for clinical trials
• Specimen storage management
• Providing industry and academia resources for the advancement of Personalized Medicine

ACORN established the World BioBank to support the pharmacogenetic studies needed to facilitate the development of personalized medicine in oncology. World BioBank adheres to best practice standards as it serves both industry and academia, collecting quality human bio-specimens, both solid and liquid, of all disease types. Along with the capability of collecting virtually any sample type (in any media or storage state), World BioBank offers sponsors standardized collection SOPs and well-documented data points (including collection times, storage times, ischemic times), even on peripheral blood samples. Clearly defined ownership, IP, and valid informed consent along with robust quality assurance and control distinguish World BioBank samples. Researchers can rely upon WorldBioBank’s verification and documentation of samples (including histologic cellular composition) as well as highest-quality, deep, longitudinal clinical data, including outcomes.

For more information on the World BioBank, visit www.worldbiobank.net.